Are Options Traders Betting on a Big Move in Merck Stock?

02.06.25 15:22 Uhr

Werte in diesem Artikel
Aktien

67,80 EUR 0,90 EUR 1,35%

115,20 EUR -0,40 EUR -0,35%

Indizes

PKT PKT

PKT PKT

2.062,6 PKT 10,8 PKT 0,53%

2.125,8 PKT 14,4 PKT 0,68%

24.091,6 PKT 161,0 PKT 0,67%

9.026,0 PKT 60,3 PKT 0,67%

1.873,0 PKT 5,7 PKT 0,30%

2.975,3 PKT 0,8 PKT 0,03%

2.143,9 PKT 0,6 PKT 0,03%

200,9 PKT 0,9 PKT 0,43%

42.519,6 PKT 214,2 PKT 0,51%

566,2 PKT 1,3 PKT 0,22%

12.599,8 PKT 70,1 PKT 0,56%

24.215,0 PKT 84,0 PKT 0,35%

24.194,3 PKT 106,2 PKT 0,44%

16.867,1 PKT 48,1 PKT 0,29%

9.310,0 PKT 57,5 PKT 0,62%

17.503,8 PKT 39,7 PKT 0,23%

2.915,1 PKT 15,8 PKT 0,54%

5.970,4 PKT 34,4 PKT 0,58%

24.201,6 PKT 63,6 PKT 0,26%

Investors in Merck & Co., Inc. MRK need to pay close attention to the stock based on moves in the options market lately. That is because the June 20, 2025 $55.00 Call had some of the highest implied volatility of all equity options today.What is Implied Volatility?Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon that may cause a big rally or a huge sell-off. However, implied volatility is only one piece of the puzzle when putting together an options trading strategy.What do the Analysts Think?Clearly, options traders are pricing in a big move for Merck shares, but what is the fundamental picture for the company? Currently, Merck is a Zacks Rank #3 (Hold) in the Large Cap Pharmaceuticals industry that ranks in the Top 17% of our Zacks Industry Rank. Over the last 60 days, no analysts have increased their earnings estimates for the current quarter, while six have dropped their estimates. The net effect has taken our Zacks Consensus Estimate for the current quarter from earnings of $2.18 per share to $2.03 in that period.Given the way analysts feel about Merck right now, this huge implied volatility could mean there’s a trade developing. Oftentimes, options traders look for options with high levels of implied volatility to sell premium. This is a strategy many seasoned traders use because it captures decay. At expiration, the hope for these traders is that the underlying stock does not move as much as originally expected.Looking to Trade Options?Check out the simple yet high-powered approach that Zacks Executive VP Kevin Matras has used to close recent double and triple-digit winners. In addition to impressive profit potential, these trades can actually reduce your risk.Click to see the trades now >>Zacks Names #1 Semiconductor StockIt's only 1/9,000th the size of NVIDIA which skyrocketed more than +800% since we recommended it. NVIDIA is still strong, but our new top chip stock has much more room to boom.With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $803 billion by 2028.See This Stock Now for Free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Merck & Co., Inc. (MRK): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Merck und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Merck

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Merck

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Merck KGaA

Wer­bung

Analysen zu Merck KGaA

DatumRatingAnalyst
03.06.2025Merck OverweightJP Morgan Chase & Co.
30.05.2025Merck BuyDeutsche Bank AG
27.05.2025Merck Market-PerformBernstein Research
16.05.2025Merck BuyGoldman Sachs Group Inc.
16.05.2025Merck BuyDeutsche Bank AG
DatumRatingAnalyst
03.06.2025Merck OverweightJP Morgan Chase & Co.
30.05.2025Merck BuyDeutsche Bank AG
16.05.2025Merck BuyGoldman Sachs Group Inc.
16.05.2025Merck BuyDeutsche Bank AG
16.05.2025Merck BuyUBS AG
DatumRatingAnalyst
27.05.2025Merck Market-PerformBernstein Research
28.04.2025Merck Market-PerformBernstein Research
10.04.2025Merck Market-PerformBernstein Research
06.03.2025Merck Market-PerformBernstein Research
07.01.2025Merck Market-PerformBernstein Research
DatumRatingAnalyst
06.03.2023Merck VerkaufenDZ BANK
02.03.2023Merck SellGoldman Sachs Group Inc.
07.02.2023Merck SellGoldman Sachs Group Inc.
02.02.2023Merck VerkaufenDZ BANK
15.11.2022Merck SellGoldman Sachs Group Inc.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Merck KGaA nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen